Louis Kayitalire

Louis Kayitalire, MD, currently serves as a Board Member for Gustave Roussy Alumni and Chief Medical Officer at Nanobiotix, with previous experience as Chief Medical Officer at F-star Biotechnology Ltd and BioAlliance Pharma. Louis has held significant roles at Bristol-Myers Squibb, including Vice President of Immuno-Oncology in Global Clinical Research, and at Celgene as Vice President. Additional experience includes a Medical Director position at Bristol-Myers Squibb and key roles at Eli Lilly, where Louis was the Senior Clinical Research Physician and Medical lead of the Oncology Therapeutic department. Louis Kayitalire obtained a degree in Clinical Oncology from Paris-Sud University (Paris XI).